The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
4
- 1
Bu, Xianyong
Company Director born in May 1970Individual (1 offspring)Officer
2011-05-06 ~ nowOF - Director → CIF 0 - 2
Mao, Daniel Ning
Director born in August 1988Individual (1 offspring)Officer 2023-08-28 ~ nowOF - Director → CIF 0 - 3
Bury, Simon Andrew
Director born in March 1958Individual (2 offsprings)Officer 2022-07-26 ~ nowOF - Director → CIF 0 - 4
P O Box 309, Ugland House, Grand Cayman, Ky1-1104, Cayman IslandsCorporate (1 offspring)Person with significant control 2023-03-30 ~ nowPE - Ownership of voting rights - 75% or more → CIF 0PE - Ownership of shares – 75% or more → CIF 0
Ceased
7
- 1
Wilks, Andrew Frederick, Professor
Company Director born in February 1956Individual (3 offsprings)Officer 2011-05-06 ~ 2021-02-26OF - Director → CIF 0Mr Andrew Frederick Wilks
Born in February 1956Individual (3 offsprings)Person with significant control 2016-04-06 ~ 2021-02-26PE - Has significant influence or control → CIF 0 - 2
Kahan, Barbara
Director born in June 1931Individual (463 offsprings)Officer 2011-05-06 ~ 2011-05-06OF - Director → CIF 0 - 3
Ye, Zhixiong
Director born in January 1960IndividualOfficer 2022-07-26 ~ 2023-08-28OF - Director → CIF 0 - 4
Mr Chen Cheney Mao
Born in October 1961IndividualPerson with significant control 2021-02-26 ~ 2023-03-30PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0 - 5
Bury, Simon Andrew
Consultant born in March 1958Individual (2 offsprings)Officer 2016-08-23 ~ 2021-02-21OF - Director → CIF 0 - 6
Ramsden, Nigel Grahame, Dr
Research Scientist born in February 1965Individual (1 offspring)Officer 2013-09-25 ~ 2016-04-15OF - Director → CIF 0 - 7
Dyson, Michael, Dr
Managing Director born in June 1959Individual (1 offspring)Officer 2011-05-06 ~ 2012-11-26OF - Director → CIF 0
Company in focus
SYNTHESIS MED CHEM (UK) LIMITED
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Par Value of Share
Class 1 ordinary share
12024-01-01 ~ 2024-12-31
Turnover/Revenue
1,299,252 GBP2024-01-01 ~ 2024-12-31
1,129,028 GBP2022-07-01 ~ 2023-12-31
Cost of Sales
810,864 GBP2024-01-01 ~ 2024-12-31
639,152 GBP2022-07-01 ~ 2023-12-31
Gross Profit/Loss
488,388 GBP2024-01-01 ~ 2024-12-31
489,876 GBP2022-07-01 ~ 2023-12-31
Administrative Expenses
470,293 GBP2024-01-01 ~ 2024-12-31
440,498 GBP2022-07-01 ~ 2023-12-31
Operating Profit/Loss
18,095 GBP2024-01-01 ~ 2024-12-31
49,378 GBP2022-07-01 ~ 2023-12-31
Other Interest Receivable/Similar Income (Finance Income)
3,706 GBP2024-01-01 ~ 2024-12-31
Profit/Loss on Ordinary Activities Before Tax
21,801 GBP2024-01-01 ~ 2024-12-31
49,378 GBP2022-07-01 ~ 2023-12-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
4,310 GBP2024-01-01 ~ 2024-12-31
9,592 GBP2022-07-01 ~ 2023-12-31
Profit/Loss
17,491 GBP2024-01-01 ~ 2024-12-31
39,786 GBP2022-07-01 ~ 2023-12-31
Comprehensive Income/Expense
17,491 GBP2024-01-01 ~ 2024-12-31
39,786 GBP2022-07-01 ~ 2023-12-31
Debtors
1,413,603 GBP2024-12-31
1,419,593 GBP2023-12-31
Cash at bank and in hand
1,478,582 GBP2024-12-31
1,282,710 GBP2023-12-31
Current Assets
2,892,185 GBP2024-12-31
2,702,303 GBP2023-12-31
Creditors
Current
2,800,690 GBP2024-12-31
2,628,299 GBP2023-12-31
Net Current Assets/Liabilities
91,495 GBP2024-12-31
74,004 GBP2023-12-31
Total Assets Less Current Liabilities
91,495 GBP2024-12-31
74,004 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
100 GBP2022-06-30
Retained earnings (accumulated losses)
91,395 GBP2024-12-31
73,904 GBP2023-12-31
34,118 GBP2022-06-30
Equity
91,495 GBP2024-12-31
74,004 GBP2023-12-31
34,218 GBP2022-06-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
17,491 GBP2024-01-01 ~ 2024-12-31
39,786 GBP2022-07-01 ~ 2023-12-31
Wages/Salaries
280,705 GBP2024-01-01 ~ 2024-12-31
324,522 GBP2022-07-01 ~ 2023-12-31
Social Security Costs
32,633 GBP2024-01-01 ~ 2024-12-31
41,883 GBP2022-07-01 ~ 2023-12-31
Pension & Other Post-employment Benefit Costs/Other Pension Costs
24,365 GBP2024-01-01 ~ 2024-12-31
51,812 GBP2022-07-01 ~ 2023-12-31
Staff Costs/Employee Benefits Expense
337,703 GBP2024-01-01 ~ 2024-12-31
418,217 GBP2022-07-01 ~ 2023-12-31
Average Number of Employees
52024-01-01 ~ 2024-12-31
42022-07-01 ~ 2023-12-31
Director Remuneration
124,820 GBP2024-01-01 ~ 2024-12-31
166,595 GBP2022-07-01 ~ 2023-12-31
Current Tax for the Period
9,592 GBP2022-07-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
19,351 GBP2023-12-31
Furniture and fittings
450 GBP2023-12-31
Computers
966 GBP2023-12-31
Property, Plant & Equipment - Gross Cost
20,767 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
19,351 GBP2023-12-31
Furniture and fittings
450 GBP2023-12-31
Computers
966 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
20,767 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
172,887 GBP2024-12-31
178,776 GBP2023-12-31
Amounts Owed by Group Undertakings
Current
1,239,009 GBP2024-12-31
1,239,264 GBP2023-12-31
Other Debtors
Current
-154 GBP2023-12-31
Prepayments/Accrued Income
Current
1,707 GBP2024-12-31
1,707 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
1,413,603 GBP2024-12-31
1,419,593 GBP2023-12-31
Trade Creditors/Trade Payables
Current
7,935 GBP2024-12-31
2,696 GBP2023-12-31
Amounts owed to group undertakings
Current
2,701,504 GBP2024-12-31
2,557,841 GBP2023-12-31
Corporation Tax Payable
Current
83 GBP2024-12-31
83 GBP2023-12-31
Other Creditors
Current
19,059 GBP2024-12-31
Accrued Liabilities/Deferred Income
Current
13,238 GBP2024-12-31
3,782 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2024-12-31
Profit/Loss
Retained earnings (accumulated losses)
17,491 GBP2024-01-01 ~ 2024-12-31
- Registered number 07624460
SYNTHESIS MED CHEM (UK) LIMITED
InfoC/o Kingly Jones Llp 414 Linen Hall, 162-168 Regent Street, London W1B 5TEPrivate Limited Company incorporated on 2011-05-06 (14 years 6 months). The company status is Active.The last date of confirmation statement was made at 2025-05-06CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 16 October 2025 and
licensed under the Open Government Licence v3.0.